| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 6.18 EUR | 0.05 EUR | 0.82 % |
|---|
| Vortag | 6.13 EUR | Datum | 03.01.2025 |
Franklin Genomic Advancements Fund N (acc) EUR Fonds Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 367.15% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
| 21Shares Stellar ETP | CH1109575535 | 216.44% | |
| 21Shares Cardano ETP | CH1102728750 | 207.61% | |
| 21Shares Sui Staking ETP | CH1360612159 | 144.26% | |
| 21Shares Aave ETP | CH1135202120 | 134.46% | |
| 21Shares Injective Staking ETP | CH1360612134 | 10.65% | |
| 21Shares Immutable ETP | CH1360612142 | -11.92% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 475.30% | |
| 21Shares Aave ETP | CH1135202120 | 332.51% | |
| 21Shares Stellar ETP | CH1109575535 | 244.32% | |
| 21Shares Cardano ETP | CH1102728750 | 209.77% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 145.10% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 323.11% | |
| 21Shares Aave ETP | CH1135202120 | 232.41% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 181.47% | |
| 21Shares Stellar ETP | CH1109575535 | 144.11% | |
| 21Shares Crypto Mid-Cap Index ETP | CH1130675676 | 131.62% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Solana staking ETP | CH1114873776 | 1’596.10% | |
| 21Shares Ripple XRP ETP | CH0454664043 | 585.99% | |
| 21Shares Aave ETP | CH1135202120 | 494.88% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 476.42% | |
| 21Shares Bitcoin ETP | CH0454664001 | 461.88% |
Fundamentaldaten
| Valor | 113722568 |
| ISIN | LU2387457729 |
| Emittent | Franklin Templeton International Services |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 15.10.2021 |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | EUR |
| Volumen | 3’155’238.91 |
| Depotbank | J.P. Morgan SE, Luxembourg Branch |
| Geschäftsjahresende | 30.06. |
| Berichtsstand | 06.01.2025 |
Anlagepolitik
So investiert der Franklin Genomic Advancements Fund N (acc) EUR Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.
ETP Performance: Franklin Genomic Advancements Fund N (acc) EUR Fonds
| Performance 1 Jahr | 1.81 | |
| Performance 2 Jahre | -3.74 | |
| Performance 3 Jahre | -29.69 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |